. .
.
. Mayo Clinic Health Solutions
.
. .
.

Browse Categories:
  arrow Research Tools
arrow
  arrow Diagnostics
arrow
  arrow Therapeutics
arrow
  arrow Medical Devices
arrow
  arrow Electronic Devices
arrow
  arrow Software
arrow
  arrow All Listings
arrow
arrow
  Home
arrow
  About Us
arrow
  Contact Us
arrow
arrow
  Go to mayoclinic.org
arrow
  Go to Research at Mayo Clinic
arrow
Mayo Clinic Technology
.

Detection of Isoniazid Resistant Strains of Mycobacterium Tuberculosis

Reference #:

1993-096

Inventors/Contributors

Franklin R. Cockerill III, M.D., Bruce C. Kline, Ph.D., James R. Uhl, Zelalem Temesgen, M.D.

Description

A rapid method to 1) identify Mycobacterium tuberculosis and 2) detect isoniazid resistance in Mycobacterium tuberculosis. In Mycobacterium tuberculosis, a point of mutation in the catalase gene is associated with isoniazid resistance. Isoniazid is a first line drug used to treat tuberculosis, and many strains of Mycobacterium tuberculosis have developed resistance to this drug. This method permits 1) identification of Mycobacterium tuberculosis and 2) detection of isoniazid resistance in as little as 1-2 hours, whereas other current methods to identify Mycobacterium tuberculosis and detect isoniazid resistance take several days, up to weeks.

Patent Status

button

U.S. Patent Number 5,658,733
Issued August 19, 1997

U.S. Patent Number 5,688,639
Issued November 18, 1997

U.S. Patent Number 5,922,575
Issued July 13, 1999

Europe Patent Number 0979310
Issued March 13, 2002

Contact

Barbara A. Gamez Sims, Licensing Manager
gamezsims.barbara@mayo.edu

Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905

Phone: (507) 284-8171
Fax: (507) 284-5410